Search

Bridget E. Bunner

Examiner (ID: 13118, Phone: (571)272-0881 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1647, 1644
Total Applications
1451
Issued Applications
718
Pending Applications
165
Abandoned Applications
598

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5844217 [patent_doc_number] => 20020132250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'EGF motif protein, EGFL6 materials and methods' [patent_app_type] => new [patent_app_number] => 09/981649 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 41179 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132250.pdf [firstpage_image] =>[orig_patent_app_number] => 09981649 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/981649
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein Oct 14, 2001 Issued
Array ( [id] => 6642820 [patent_doc_number] => 20030103992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Clasp membrane proteins' [patent_app_type] => new [patent_app_number] => 09/978244 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 95 [patent_figures_cnt] => 95 [patent_no_of_words] => 50740 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103992.pdf [firstpage_image] =>[orig_patent_app_number] => 09978244 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/978244
Clasp membrane proteins Oct 14, 2001 Abandoned
Array ( [id] => 6782977 [patent_doc_number] => 20030064424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Method of diagnosing transmissible spongiform encephalopathies' [patent_app_type] => new [patent_app_number] => 09/974131 [patent_app_country] => US [patent_app_date] => 2001-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6873 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064424.pdf [firstpage_image] =>[orig_patent_app_number] => 09974131 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/974131
Method of diagnosing transmissible spongiform encephalopathies Oct 7, 2001 Abandoned
Array ( [id] => 5787123 [patent_doc_number] => 20020160425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Process for differential diagnosis of Alzheimer\'s dementia and device therefor' [patent_app_type] => new [patent_app_number] => 09/971740 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7177 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160425.pdf [firstpage_image] =>[orig_patent_app_number] => 09971740 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/971740
Method for detecting the presence of monomeric brain associated human glutamine synthetase Oct 3, 2001 Issued
09/964252 56115, a novel human twik potassium channel and uses therefor Sep 24, 2001 Abandoned
Array ( [id] => 6778646 [patent_doc_number] => 20030049727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => '25658, a novel human calcium channel subunit and uses thereof' [patent_app_type] => new [patent_app_number] => 09/964256 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 39863 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049727.pdf [firstpage_image] =>[orig_patent_app_number] => 09964256 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/964256
25658, a novel human calcium channel subunit and uses thereof Sep 24, 2001 Abandoned
Array ( [id] => 6446680 [patent_doc_number] => 20020177227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Modulation of primary stem cell differentiation' [patent_app_type] => new [patent_app_number] => 09/962026 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12665 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177227.pdf [firstpage_image] =>[orig_patent_app_number] => 09962026 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/962026
Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein Sep 23, 2001 Issued
Array ( [id] => 5859033 [patent_doc_number] => 20020123098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => '55063, a novel human NMDA family member and uses thereof' [patent_app_type] => new [patent_app_number] => 09/957683 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 38361 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123098.pdf [firstpage_image] =>[orig_patent_app_number] => 09957683 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/957683
55063, a novel human NMDA family member and uses thereof Sep 18, 2001 Abandoned
Array ( [id] => 5921673 [patent_doc_number] => 20020115112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Neutrokine-alpha and Neutrokine-alpha splice variant' [patent_app_type] => new [patent_app_number] => 09/929493 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 182879 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115112.pdf [firstpage_image] =>[orig_patent_app_number] => 09929493 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/929493
Neutrokine-alpha and Neutrokine-alpha splice variant Aug 14, 2001 Abandoned
Array ( [id] => 6745642 [patent_doc_number] => 20030022825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => new [patent_app_number] => 09/912935 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 49940 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022825.pdf [firstpage_image] =>[orig_patent_app_number] => 09912935 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/912935
Stem cell growth factor-like polypeptides Jul 23, 2001 Issued
Array ( [id] => 6669415 [patent_doc_number] => 20030114399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Human and mouse choline transporter cDNA' [patent_app_type] => new [patent_app_number] => 09/911077 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 51596 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114399.pdf [firstpage_image] =>[orig_patent_app_number] => 09911077 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/911077
Human and mouse choline transporter cDNA Jul 22, 2001 Abandoned
Array ( [id] => 6865085 [patent_doc_number] => 20030190611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/907728 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 125 [patent_no_of_words] => 122300 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190611.pdf [firstpage_image] =>[orig_patent_app_number] => 09907728 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/907728
Secreted and transmembrane polypeptides and nucleic acids encoding the same Jul 16, 2001 Abandoned
Array ( [id] => 6813527 [patent_doc_number] => 20030073077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/905088 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 125 [patent_no_of_words] => 118475 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073077.pdf [firstpage_image] =>[orig_patent_app_number] => 09905088 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/905088
Secreted and transmembrane polypeptides and nucleic acids encoding the same Jul 11, 2001 Abandoned
Array ( [id] => 6750319 [patent_doc_number] => 20030044839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/902903 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 125 [patent_no_of_words] => 118323 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044839.pdf [firstpage_image] =>[orig_patent_app_number] => 09902903 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/902903
Secreted and transmembrane polypeptides and nucleic acids encoding the same Jul 9, 2001 Abandoned
Array ( [id] => 1091793 [patent_doc_number] => 06824781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'Method of impairing movement of a CLA memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist' [patent_app_type] => B2 [patent_app_number] => 09/898751 [patent_app_country] => US [patent_app_date] => 2001-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31582 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/824/06824781.pdf [firstpage_image] =>[orig_patent_app_number] => 09898751 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/898751
Method of impairing movement of a CLA memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist Jul 1, 2001 Issued
Array ( [id] => 6750272 [patent_doc_number] => 20030044792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Methods and materials relataing to novel stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => new [patent_app_number] => 09/894912 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 67617 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044792.pdf [firstpage_image] =>[orig_patent_app_number] => 09894912 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/894912
Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide Jun 27, 2001 Issued
Array ( [id] => 6209926 [patent_doc_number] => 20020072493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Activated T cells, nervous system-specific antigens and their uses' [patent_app_type] => new [patent_app_number] => 09/893348 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23035 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072493.pdf [firstpage_image] =>[orig_patent_app_number] => 09893348 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/893348
Activated T cells, nervous system-specific antigens and their uses Jun 27, 2001 Abandoned
Array ( [id] => 948940 [patent_doc_number] => 06962976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-08 [patent_title] => 'Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole' [patent_app_type] => utility [patent_app_number] => 09/892360 [patent_app_country] => US [patent_app_date] => 2001-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7526 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962976.pdf [firstpage_image] =>[orig_patent_app_number] => 09892360 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/892360
Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole Jun 26, 2001 Issued
Array ( [id] => 634008 [patent_doc_number] => 07129064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Canine hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 10/311776 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9297 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129064.pdf [firstpage_image] =>[orig_patent_app_number] => 10311776 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/311776
Canine hepatocyte growth factor Jun 21, 2001 Issued
Array ( [id] => 6847101 [patent_doc_number] => 20030166268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Mammalian transforming growth factor beta-10' [patent_app_type] => new [patent_app_number] => 09/867964 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18674 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166268.pdf [firstpage_image] =>[orig_patent_app_number] => 09867964 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/867964
Mammalian transforming growth factor beta-10 May 28, 2001 Abandoned
Menu